Feasibility and acceptability of virtual reality use during intrauterine device procedures: a London-based health service evaluation

BACKGROUND: Intrauterine devices (IUDs) are highly effective contraceptives, yet the procedures can be associated with discomfort, anxiety and pain, which deter uptake and continuation. By providing immersive, multisensory distraction, virtual reality (VR) use during IUD procedures has demonstrated multiple benefits, including reducing pain and anxiety. We evaluated the feasibility, acceptability and service impact of using VR during IUD procedures in a sexual and reproductive health clinic in London, UK. METHODS: VR was offered to patients attending IUD clinics between 20/11/24 and 05/11/25 . Patients and healthcare staff completed feedback questionnaires assessing their experience and perceived impact of VR, procedural anxiety and pain scores, and barriers and facilitators to implementation. Consultation durations were compared between the VR (20/11/24-05/11/25) and pre-VR (1/8/24-31/10/24) periods. RESULTS: Of 235 patients offered VR, 177 (75%) accepted. Among VR acceptors, 93% (165/177) would use it again, 96% (170/177) would recommend it and 86% (80/93) reported that it provided a superior experience to previous fitting(s). All staff reported that VR was helpful, improved care and increased positive feedback, and 80% (12/15) felt it helped them perform their role more effectively.Baseline anxiety scores were higher among VR acceptors (mean=56.7/100, SD=26.8) than decliners (mean=46.2/100, SD=30.6) (p=0.02) and 87% of VR acceptors felt it reduced their anxiety. Appointment durations did not appreciably differ between pre-VR (36.5 min) versus VR (37 min) periods. CONCLUSIONS: VR as a non-pharmacological adjunct in National Health Service IUD clinics was feasible and acceptable among patients and clinicians, without prolonging appointments. Patients who accepted VR reported higher baseline anxiety than decliners, and the majority perceived VR reduced anxiety and provided a superior experience.

Authors

Institutions

Publication Details

Journal
BMJ Sexual & Reproductive Health
Published
2026-04-15
DOI
https://doi.org/10.1136/bmjsrh-2025-203145
Primary Topic
Reproductive Health and Contraception
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Feasibility and acceptability of virtual reality use during intrauterine device procedures: a London-based health service evaluation

Kimberley Forbes, Praveen Jayadeva, Sara Day, Gurmit Jagjit Singh et al.
BMJ Sexual & Reproductive Health
Reproductive Health and Contraception
article

Feasibility and acceptability of virtual reality use during intrauterine device procedures: a London-based health service evaluation

Kimberley Forbes, Praveen Jayadeva, Sara Day, Gurmit Jagjit Singh, Joanna Burgess, Jessica Collins, Nicole Alexiuk
article en

Abstract

BACKGROUND: Intrauterine devices (IUDs) are highly effective contraceptives, yet the procedures can be associated with discomfort, anxiety and pain, which deter uptake and continuation. By providing immersive, multisensory distraction, virtual reality (VR) use during IUD procedures has demonstrated multiple benefits, including reducing pain and anxiety. We evaluated the feasibility, acceptability and service impact of using VR during IUD procedures in a sexual and reproductive health clinic in London, UK. METHODS: VR was offered to patients attending IUD clinics between 20/11/24 and 05/11/25 . Patients and healthcare staff completed feedback questionnaires assessing their experience and perceived impact of VR, procedural anxiety and pain scores, and barriers and facilitators to implementation. Consultation durations were compared between the VR (20/11/24-05/11/25) and pre-VR (1/8/24-31/10/24) periods. RESULTS: Of 235 patients offered VR, 177 (75%) accepted. Among VR acceptors, 93% (165/177) would use it again, 96% (170/177) would recommend it and 86% (80/93) reported that it provided a superior experience to previous fitting(s). All staff reported that VR was helpful, improved care and increased positive feedback, and 80% (12/15) felt it helped them perform their role more effectively.Baseline anxiety scores were higher among VR acceptors (mean=56.7/100, SD=26.8) than decliners (mean=46.2/100, SD=30.6) (p=0.02) and 87% of VR acceptors felt it reduced their anxiety. Appointment durations did not appreciably differ between pre-VR (36.5 min) versus VR (37 min) periods. CONCLUSIONS: VR as a non-pharmacological adjunct in National Health Service IUD clinics was feasible and acceptable among patients and clinicians, without prolonging appointments. Patients who accepted VR reported higher baseline anxiety than decliners, and the majority perceived VR reduced anxiety and provided a superior experience.

BMJ Sexual & Reproductive Health
Chelsea and Westminster Hospital NHS Foundation Trust (GB)
CW+
Good health and well-being
Openalex Percentile: Top 19%
Reproductive Health and Contraception
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.